Have a personal or library account? Click to login
Hydroxyapatite-ciprofloxacin delivery system: Synthesis, characterisation and antibacterial activity Cover

Hydroxyapatite-ciprofloxacin delivery system: Synthesis, characterisation and antibacterial activity

Open Access
|Apr 2018

References

  1. 1. M. Panteli and P. V. Giannoudis, Chronic osteomyelitis: what the surgeon needs to know, Efort. Open Rev.1 (2016) 128–135; http://doi.org/10.1302/2058-5241.1.00001710.1302/2058-5241.1.000017536761228461939
  2. 2. H. S. Fraimow, Systemic Antimicrobial Therapy in Osteomyelitis, Semin. Plast. Surg.23 (2009) 90–99; http://doi.org/10.1055/s-0029-121416110.1055/s-0029-1214161288490520567731
  3. 3. D. Bamberger and S. Boyd, Management of Staphylococcus aureus infections, Am. Fam. Physician.72 (2005) 2474–2481.
  4. 4. M. E. Olson and A. R. Horswill, Staphylococcus aureus osteomyelitis: bad to the bone, Cell Host Microbe13 (2013) 629–631; http://doi.org/10.1016/j.chom.2013.05.01510.1016/j.chom.2013.05.015373283423768487
  5. 5. E. Goldstein, Systemic antibiotic therapy for chronic osteomyelitis in adults, Clin. Infect. Dis.54 (2012) 393–407; http://doi.org/10.1093/cid/cir84210.1093/cid/cir842349185522157324
  6. 6. J. Kelm, T. Regitz, E. Schmitt, W. Jung and K. Anagnostakos, In vivo and in vitro studies of antibiotic release from and bacterial growth inhibition by antibiotic-impregnated polymethylmethacrylate hip spacers, Antimicrob. Agents Chemother.50 (2006) 332–335; http://doi.org/10.1128/AAC.50.1.332-335.200610.1128/AAC.50.1.332-335.2006134677316377705
  7. 7. J. S. Gogia, J. P. Meehan, P. E. Cesare and A. A. Jamali, Local antibiotic therapy in osteomyelitis, Semin Plast Surg.23 (2009) 100–107; http://doi.org/10.1055/s-0029-121416210.1055/s-0029-1214162288490620567732
  8. 8. O. S. Kluin, H. C. van der Mei, H. J. Busscher and D. Neut, Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis, Expert Opin. Drug Deliv.10 (2013) 341–351; http://doi.org/10.1517/17425247.2013.75137110.1517/17425247.2013.75137123289645
  9. 9. W. Habraken, P. Habibovic, M. Epple and M. Bohner, Calcium phosphates in biomedical applications: materials for the future? Materials Today19 (2016) 69–87; http://doi.org/10.1016/j.mattod.2015.10.00810.1016/j.mattod.2015.10.008
  10. 10. K. Uemura, A. Kanamori, K. Aoto, M. Yamazaki and M. Sakane, Novel unidirectional porous hydroxyapatite used as a bone substitute for open wedge high tibial osteotomy, J. Mater. Sci. Mater. Med.25 (2014) 2541–2547; http://doi.org/10.1007/s10856-014-5266-510.1007/s10856-014-5266-5419880924997164
  11. 11. D. Neut, R. J. B. Dijkstra, J. I. Thompson, C. Kavanagh, H. C. van der Mei, and H. J. Busscher, A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses, Eur. Cell Mater.29 (2015) 42–56; http://doi.org/10.22203/eCM10.22203/eCM
  12. 12. G. Shazly and K. Mohsin, Dissolution improvement of solid self-emulsifying drug delivery systems of fenofibrate using an inorganic high surface adsorption material, Acta Pharm. 65 (2015) 29–42; http://doi.org/10.1515/acph-2015-000310.1515/acph-2015-0003
  13. 13. G. Devanand Venkatasubbu, S. Ramasamy, V. Ramakrishnan and J. Kumar, Nanocrystalline hydroxyapatite and zinc doped hydroxyapatite as carrier material for controlled delivery of ciprofloxacin, 3 Biotech. 1 (2011) 173–186; http://doi.org/10.1007/s13205-011-0021-910.1007/s13205-011-0021-9
  14. 14. D. P. Minh, N. D. Tran, A. Nzihou and P. Sharrock, One-step synthesis of calcium hydroxyapatite from calcium carbonate and orthophosphoric acid under moderate conditions, Ind. Eng. Chem. Res. 52 (2013) 1439–1447; http://doi.org/10.1021/ie302422d10.1021/ie302422d
  15. 15. A. Mocanu, R. Melinte, M. Popescu, C. V. Manda, O. Croitoru, J. Neamţu and M. V Bubulică, Synthesis and physico-chemical characterization of a hydroxyapatite-ciprofloxacin composite, Curr. Health Sci. J.40 (2014) 30–34.
  16. 16. S. K. Padhyay, P. Kumar and V. Arora, Complexes of quinolone drugs norfloxacin and ciprofloxacin with alkaline earth metal perchlortes, J. Struct. Chem. 47 (2006) 1078–1083.10.1007/s10947-006-0428-z
  17. 17. J. Neamtu, M. V. Bubulica, A. Rotaru, C. Ducu, O. E. Balosache, V. C. Manda, A. Turcu-Stiolica, C. Nicolicescu, R. Melinte, M. Popescu and O. Croitoru, Hydroxyapatite-alendronate composite systems for biocompatible materials, J. Therm. Anal. Calorim.127 (2017) 1567–1582; http://doi.org/10.1007/s10973-016-5905-910.1007/s10973-016-5905-9
  18. 18. M. J. Lukić, L. J. Veselinović, Z. Stojanović, M. Maček-Kržmanc, I. Bračko, S. D. Škapin, S. Marković and D. Uskoković, Peculiarities in sintering behavior of Ca-deficient hydroxyapatite nanopowders, Mater. Lett.68 (2012) 331–335; http://doi.org/10.1016/j.matlet.2011.10.08510.1016/j.matlet.2011.10.085
  19. 19. I. Turel, N. Bukovec and E. Farkas, Complex formation between some metals and a quinolone family member (ciprofloxacin), Polyhedron15 (1996) 269–275; http://doi.org/10.1016/0277-5387(95)00231-G10.1016/0277-5387(95)00231-G
  20. 20. A. Destainville, E. Champion and D. Bernache-Assollante, Synthesis, characterization and thermal behaviour of apatite tricalcium phosphate, Mater. Chem. Phys.80 (2003) 269–277.10.1016/S0254-0584(02)00466-2
  21. 21. I. Mobasherpour and M. Heshajin, Synthesis of nanocrystalline hydroxyapatite by using precipitation method, J. Alloys Compd.430 (2007) 330–333; http://doi.org/10.1016/j.jallcom.2006.05.01810.1016/j.jallcom.2006.05.018
  22. 22. V. Uivarosi, Metal complexes of quinolone antibiotics and their applications: An update, Molecules18 (2013) 11153–11197; http://doi.org/10.3390/molecules18091115310.3390/molecules180911153626984824029748
  23. 23. G. B. Deacon and R. J. Phillips, Relationships between the carbon-oxygen stretching frequencies of arboxylato complexes and the type of carboxylate coordination, Coord. Chem. Rev.33 (1980) 227–250; http://doi.org/10.1016/S0010-8545(00)80455-510.1016/S0010-8545(00)80455-5
  24. 24. J. Barbosa, R. Berge´s, I. Toro and V. Sanz-Nebot, Protonation equilibria of quinolone antibacterials in acetonitrile-water mobile phases used in LC, Talanta44 (1997) 1271–1283; http://doi.org/10.1016/S0039-9140(96)02188-110.1016/S0039-9140(96)02188-1
  25. 25. S. G. Kumar, R. Govindana and E. K. Girija, In situ synthesis, characterization and in vitro studies of ciprofloxacin loaded hydroxyapatite nanoparticles for the treatment of osteomyelitis, J. Mater. Chem. B2 (2014) 5052–5060; http://doi.org/10.1039/C4TB00339J10.1039/C4TB00339J32261838
  26. 26. M. Rauschmann, T. Wichelaus, V. Stirnal, E. Dingeldein, L. Zichner, R. Schnettler and V. Alt, Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections, Biomater.26 (2005) 2677–2684; http://doi.org/10.1016/j.biomaterials.2004.06.04510.1016/j.biomaterials.2004.06.04515585271
  27. 27. N. Rameshbabu, T. S. S. Kumar, T. G. Prabhakar, V. S. Sastry, K. V. Murty and K. P. Rao, Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization, J. Biomed. Mater. Res. A. 80 (2007) 581–591; http://doi.org/10.1002/jbm.a.3095810.1002/jbm.a.3095817031822
  28. 28. W. K. Jung, H. C. Koo, K. W. Kim, S. Shin, S. H. Kim and Y. H. Park, Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli, Appl. Environ. Microbiol.74 (2008) 2171–2178.10.1128/AEM.02001-07229260018245232
  29. 29. R. C. Li, D. E. Nix and J. J. Schentag, Interaction between ciprofloxacin and metal cations: Its influence on physicochemical characteristics and antibacterial activity, Pharm. Res.11 (1994) 917–920; http://doi.org/10.1023/A:101895453025010.1023/A:1018954530250
  30. 30. A. Heijink, M. J. Yaszemski, R. Patel, M. S. Rouse, D. G. Lewallen and A. D. Hanssen, Local antibiotic delivery with OsteoSet, DBX, and Collagraft, Clin. Orthop. Relat. Res. 451 (2006) 29–33; http://doi.org/10.1097/01.blo.0000229319.45416.8110.1097/01.blo.0000229319.45416.8116906070
DOI: https://doi.org/10.2478/acph-2018-0011 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 129 - 144
Accepted on: Dec 9, 2017
Published on: Apr 26, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Maria-Viorica Ciocilteu, Andreea Gabriela Mocanu, Adriana Mocanu, Catalin Ducu, Oana Elena Nicolaescu, Valentin Costel Manda, Adina Turcu-Stiolica, Claudiu Nicolicescu, Razvan Melinte, Maria Balasoiu, Octavian Croitoru, Johny Neamtu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.